Loading company…

USD millions

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

Revenue

17,365

15,828

14,282

13,399

12,642

11,559

11,378

10,772

10,410

9,766

9,043

8,205

Net income

1,489

1,142

718

676

992

944

815

780

752

702

681

545

Diluted EPS

23.10

16.82

10.23

9.14

11.82

10.99

9.13

8.31

7.81

7.14

6.76

5.42

Diluted shares

101

Operating cash flow

1,864

2,067

1,268

996

884

2,360

1,438

1,275

1,248

1,334

1,068

1,036

Capital expenditures

1,015

944

743

734

856

731

634

665

558

520

379

391

Free cash flow

849

1,123

525

262

1,629

804

610

690

814

689

645

Cash & equivalents

138

126

119

103

115

1,224

105

Total assets

15,528

14,470

13,968

13,494

13,094

13,477

11,668

11,265

10,762

10,318

9,615

8,974

Shareholders' equity

7,276

6,666

6,149

5,921

6,090

6,317

5,504

5,389

4,990

4,533

4,250

3,736

UNIVERSAL HEALTH SERVICES INC

UHSCIK 000035291518 fiscal years

RevenueFY2025

$17.36B9.7%

Net incomeFY2025

$1.49B30.4%

Free cash flowFY2025

$849.2M24.4%

Diluted EPSFY2025

$23.1037.3%

Trends

FY2010–FY2025 · hover a year for its filing

Revenue & net incomeRevenueNet income

revenue 3.5× since FY2010 · net margin 4.7% → 8.6%

MarginsNet marginFCF margin

FY2025: net 8.6% · free cash flow 4.9% of revenue

Cash flowOperating cash flowFree cash flow

FY2025: $1.86B operating cash − $1.02B capex = $849.2M free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 15% (FY2009) → 20% (FY2025) · on assets 9.6%

Financial statements

Annual Quarterly

USD millions, except per-share values; share counts in millions. Hover a value for its XBRL tag and filing accession.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	17,365	15,828	14,282	13,399	12,642	11,559	11,378	10,772	10,410	9,766	9,043	8,205
Net income	1,489	1,142	718	676	992	944	815	780	752	702	681	545
Diluted EPS	23.10	16.82	10.23	9.14	11.82	10.99	9.13	8.31	7.81	7.14	6.76	5.42
Diluted shares	64	68	70	74	84	86	89	94	96	98	101	101
Operating cash flow	1,864	2,067	1,268	996	884	2,360	1,438	1,275	1,248	1,334	1,068	1,036
Capital expenditures	1,015	944	743	734	856	731	634	665	558	520	379	391
Free cash flow	849	1,123	525	262	28	1,629	804	610	690	814	689	645
Cash & equivalents	138	126	119	103	115	1,224	61	105	74	34	61	32
Total assets	15,528	14,470	13,968	13,494	13,094	13,477	11,668	11,265	10,762	10,318	9,615	8,974
Shareholders' equity	7,276	6,666	6,149	5,921	6,090	6,317	5,504	5,389	4,990	4,533	4,250	3,736

As reported in SEC filings; a missing tag shows “—”, never zero. Free cash flow is operating cash flow − capex. Methodology